Literature DB >> 21812629

Value of quantitative analysis of routine clinical MRI sequences in ALS.

Xiao-Qi Ding1, Katja Kollewe, Katrin Blum, Sonja Körner, Sonja Kehbel, Reinhard Dengler, Heinrich Lanfermann, Susanne Petri.   

Abstract

Simple morphological assessment of conventional MRI used in routine neurological diagnostic work-up lacks sensitivity and specificity for amyotrophic lateral sclerosis (ALS). Quantitative analysis of routine MRI sequences might, however, be more suitable to reveal ALS-related pathological cerebral alterations. We investigated 10 ALS patients and 10 age- and sex-matched healthy controls by MRI. Brain maps of T2 relaxation time (T2), relative proton density (PD), and apparent diffusion coefficient (ADC) were obtained. Values of these parameters were measured in 22 selected brain regions, and compared among the patients and the controls by using paired t-test with Bonferroni corrected alpha level (= 0.002). In ALS patients, increased PD was found in the pyramidal tract, corpus callosum, and white and grey matter. T2 elongation was found at the genu of corpus callosum, and at the posterior limb of the internal capsule (ICP). ADC values showed a tendency towards an increase in patients, which was only significant at the ICP. PD therefore appeared to be the most sensitive parameter for the detection of degenerative changes not only in the motor system but also in extramotor brain regions.

Entities:  

Mesh:

Year:  2011        PMID: 21812629     DOI: 10.3109/17482968.2011.597402

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  8 in total

1.  Precentral degeneration and cerebellar compensation in amyotrophic lateral sclerosis: A multimodal MRI analysis.

Authors:  Ting Qiu; Yuanchao Zhang; Xie Tang; Xiaoping Liu; Yue Wang; Chaoyang Zhou; Chunxia Luo; Jiuquan Zhang
Journal:  Hum Brain Mapp       Date:  2019-04-24       Impact factor: 5.038

Review 2.  Pharmacological MRI (phMRI) of the Human Central Nervous System.

Authors:  H Lanfermann; C Schindler; J Jordan; N Krug; P Raab
Journal:  Clin Neuroradiol       Date:  2015-09-02       Impact factor: 3.649

3.  Voxel-based MRI intensitometry reveals extent of cerebral white matter pathology in amyotrophic lateral sclerosis.

Authors:  Viktor Hartung; Tino Prell; Christian Gaser; Martin R Turner; Florian Tietz; Benjamin Ilse; Martin Bokemeyer; Otto W Witte; Julian Grosskreutz
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

4.  Distinct patterns of progressive gray and white matter degeneration in amyotrophic lateral sclerosis.

Authors:  Abdullah Ishaque; Daniel Ta; Muhammad Khan; Lorne Zinman; Lawrence Korngut; Angela Genge; Annie Dionne; Hannah Briemberg; Collin Luk; Yee-Hong Yang; Christian Beaulieu; Derek Emery; Dean T Eurich; Richard Frayne; Simon Graham; Alan Wilman; Nicolas Dupré; Sanjay Kalra
Journal:  Hum Brain Mapp       Date:  2021-12-15       Impact factor: 5.038

Review 5.  Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Robert Bowser; Lucie Bruijn; Luc Dupuis; Albert Ludolph; Michael McGrath; Giovanni Manfredi; Nicholas Maragakis; Robert G Miller; Seth L Pullman; Seward B Rutkove; Pamela J Shaw; Jeremy Shefner; Kenneth H Fischbeck
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05       Impact factor: 4.092

6.  Magnetic resonance imaging in amyotrophic lateral sclerosis.

Authors:  Katja Kollewe; Sonja Körner; Reinhard Dengler; Susanne Petri; Bahram Mohammadi
Journal:  Neurol Res Int       Date:  2012-07-09

Review 7.  The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review.

Authors:  G Grolez; C Moreau; V Danel-Brunaud; C Delmaire; R Lopes; P F Pradat; M M El Mendili; L Defebvre; D Devos
Journal:  BMC Neurol       Date:  2016-08-27       Impact factor: 2.474

8.  Quantitative FLAIR MRI in Amyotrophic Lateral Sclerosis.

Authors:  Jeremy Fabes; Lucy Matthews; Nicola Filippini; Kevin Talbot; Mark Jenkinson; Martin R Turner
Journal:  Acad Radiol       Date:  2017-05-29       Impact factor: 3.173

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.